Multidrug-Resistant variants of HIV Type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants

Journal of Infectious Diseases

Volumn 200, Issue 9, 2009, Pages 1479-1483

  Quan, Yudong ^a   Liang, Chen ^a   Brenner, Bluma G ^a   Wainberg, Mark A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROVIRUS; SUPERINFECTION;

CELL LINE; DEFECTIVE VIRUSES; DRUG RESISTANCE, MULTIPLE, VIRAL; HIV-1; HUMANS; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; SUPERINFECTION;

EID: 72849109704     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/606117     Document Type: Article

References (16)

1. Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997; 51:151-78.
2. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267:483-9.
3. Quan Y, Brenner BG, Dascal A, et al. Highly diversified multiply drugresistant HIV-1 quasispecies in PBMCs: a case report. Retrovirology 2008; 5:43.
4. Sanchez G, Xu X, Chermann JC, Hirsch I. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J Virol 1997; 71:2233-40.
5. Li Y, Kappes JC, Conway JA, et al. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and-defective viral genomes. J Virol 1991; 65:3973-85.
6. Boulerice F, Bour S, Geleziunas R, et al. High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells. J Virol 1990; 64: 1745-55.
7. Tominaga K, Kato S, Negishi M, et al. A high frequency of defective vif genes in peripheral blood mononuclear cells from HIV type 1-infected individuals. AIDS Res Hum Retroviruses 1996; 12:1543-9.
8. Liang C, Hu J, Whitney JB, et al. A structurally disordered region at the C-terminus of capsid plays essential roles in multimerization and membrane-binding of the Gag protein of human immunodeficiency virus type 1. J Virol 2003; 77:1772-83.
9. Saphire EO, Parren PW, Pantophlet R, et al. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 2001; 293:1155-9.
10. Palmer S, Kearney M, Maldarelli F, et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol 2005; 43:406-13.
11. Jung A, Maier R, Vartanian JP, et al. Multiply infected spleen cells in HIV patients. Nature 2002; 418:144.
12. Inoue M, Hoxie JA, Reddy MV, et al. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses. Proc Natl Acad Sci U S A 1991;88: 2278-82.
13. Li Y, Migueles SA, Welcher B, et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 2007; 13:1032-4.
14. Darwich L, Esteve A, Ruiz L, et al. Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions. AIDS Res Hum Retroviruses 2008; 24:725-32.
15. Iwabu Y, Mizuta H, Kawase M, et al. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Microbes Infect 2008; 10:504-13.
16. Smith AJ, Cho MI, Hammarskjöld ML, Rekosh D. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J Virol 1990; 64:274350.